| Trial ID: | L0045 |
| Source ID: | NCT02263677
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
|
| Acronym: |
--
|
| Status: |
Withdrawn
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type 2 Diabetes|Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Sitagliptin
|
| Outcome Measures: |
Change in Liver steatosis
|
| Sponsor/Collaborators: |
University of Missouri-Columbia
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
0
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
March 2014
|
| Completion Date: |
January 2016
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 5, 2016
|
| Locations: |
University of Missouri-Columbia: Diabetes Center, Columbia, Missouri, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT02263677
|
